Hongxia Fu

University of Washington

Papers

1

Total Citations

461

H-Index

1

About

Hongxia Fu is a leading figure in stem cell biology and organoid engineering, whose work has significantly advanced the development of human kidney organoids from pluripotent stem cells. Her landmark 2018 study, cited over 460 times, introduced a high-throughput screening platform that not only enhanced the differentiation efficiency of kidney organoids but also enabled automated, multidimensional phenotyping. This breakthrough provided a scalable, reproducible method for generating complex kidney tissues, opening new avenues for disease modeling, drug screening, and regenerative medicine. Fu’s contributions have been instrumental in bridging the gap between basic stem cell research and practical biomedical applications, demonstrating how systematic, automated approaches can overcome the variability and low yield that historically plagued organoid generation. Her work is widely recognized for its technical rigor and translational potential, making her a key innovator in the field. By integrating cutting-edge screening technologies with stem cell biology, Hongxia Fu has set a new standard for organoid production, inspiring further research into high-throughput methods for other tissue types and solidifying her reputation as a pioneer in the next generation of tissue engineering.

Research Focus

Key Achievements

1
H-Index
1
Papers
461
Total Citations
461
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping
461 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University of Washington

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago